Satellos Bioscience Inc. (MSLE)
MSLE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.04
-1.81% on the day
Market cap
$149.4M
Micro cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MSLE on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001421642 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | Z4 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 40-F | 2026-03-27 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-05 |
Source: SEC EDGAR submissions feed, 51 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NBP | NovaBridge Biosciences | $1.29 | -2.27% | $148.8M |
| NKTX | Nkarta Inc. | $2.10 | -3.23% | $150.4M |
| MENS | Jyong Biotech Ltd. | $2.04 | -2.86% | $155.1M |
| ORGO | Organogenesis Holdings Inc. | $1.21 | -1.63% | $155.7M |
| CUE | Cue Biopharma Inc. | $19.57 | -20.48% | $142.2M |
| BGM | BGM Group Ltd. | $10.48 | +2.75% | $140.0M |
| DERM | Journey Medical Corporation | $5.68 | -3.89% | $160.3M |
| TLSA | Tiziana Life Sciences Ltd. Common Shares | $1.09 | 0.00% | $138.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier